The FBLN2 gene is silenced through methylation or deletion in various tumor types, and reintroduction of fibulin-2 into cancer cells that do not express fibulin-2 reduces motility and invasion in vitro [19–22]. The gene discussed is FBLN2; the disease is cancer.